IL17F: Interleukin-17F
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Effector cytokine of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity.
- Drugs that act on it: 2
- With a US drug page: 1
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Bimekizumab | Approved | Interleukin-17F inhibitor | Inhibitor | — |
| M-1095 | — | Interleukin-17F inhibitor | Inhibitor | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Chronic mucocutaneous candidiasis
- 0.58
- Psoriasis
- 0.57
- Psoriasis vulgaris
- 0.52
- Erythematosquamous dermatosis
- 0.44
- Immune system disorder
- 0.37
- Parapsoriasis
- 0.37
- Enthesitis-related juvenile idiopathic arthritis
- 0.27
Drugs and mechanisms are from ChEMBL CHEMBL4630880 (CC BY-SA 3.0). Gene name, function (UniProt Q96PD4, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets